Clinical trial · Observational
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
NCT06824727CI-TRIAL-00094613completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of the research project is to collect one blood sample from participants who are affected by very low platelets as a result of their condition or their treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Thrombocytopenia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Baseline cell blood counts | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Sample Collection
- interventionNames
- Other: Baseline cell blood counts
Primary outcomes (1)
- measure
- Sample collection of peripheral blood from patients experiencing thrombocytopenia
- timeFrame
- Baseline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 88 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adults 18 years or older 2. Platelet counts of 30,000/mcl or less Exclusion Criteria: 1. Chemotherapy within the last 24 hours from the planned blood sample draw for research purposes. 2. Use of anticoagulant agents in the last 48 hours. 3. Active infection (i.e. one that has received less than 48 hours of active treatment). 4. Adults 89 years or older
References
Publications (0)
Data not yet available
No reference posted for this study.